in this issue
Regions :: Western Europe :: Sweden
MPA inspection completed at Cambrex API facility in Sweden
7:56 AM MDT | March 27, 2014 | Deepti Ramesh
Cambrex (East Rutherford, NJ) says that the Medical Products Agency (MPA; Uppsala, Sweden) completed an inspection of Cambrex’s active pharmaceutical ingredient (API) manufacturing facility at Karlskoga, Sweden. The inspection found the site to be compliant with the principles and guidelines of GMP, and the site’s GMP certificate was renewed. The MPA authorities inspected the facility in September 2013. MPA is the Swedish national authority responsible for regulation and surveillance of the development, manufacturing, and sale of drugs and other...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee